Atsushi Marumo

Atsushi Marumo

Auto-generated profile, based on publicly available information

Atsushi Marumo

Department of Hematology Nippon Medical School Tokyo Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Closed access
AMAtsushi Marumo
Atsushi Marumo
IOIkuko Omori
Ikuko Omori
STShuhei Tara
Shuhei Tara
YOYuki Otsuka
Yuki Otsuka
RKRyosuke Konuma
Ryosuke Konuma
NDNoriko Doki
Noriko Doki

1 January 2021 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
AMAtsushi Marumo
Atsushi Marumo
TYTakuya Yamamura
Takuya Yamamura
TMTaro Mizuki
Taro Mizuki
STSakae Tanosaki
Sakae Tanosaki
KSKen Suzuki
Ken Suzuki
Erythropoiesis-stimulating agent (ESA) has been recognized as an effective way in the treatment of anemia due to chronic kidney disease, but we sometimes see intractable hemodialysis (HD) patients. The causes of ESA-resistant anemia in HD patients include deficiency of trace elements. We report the case of an 89-year-old male who developed pancytopenia after taking an excessive amount of zinc formulation for ESA-resistant anemia during maintenance dialysis. He was prescribed zinc acetate hydrate formulation about 6 months before his presentation. He was found to have pancytopenia 1 month before his presentation, at which point he was introduced to our hospital. We suspected a copper deficiency at the first visit and stopped zinc and added copper, and his condition subsequently improved without being handicapped. Zinc antagonizes copper, so we must take care to diagnose patients ingesting zinc supplements.

17 October 2024 in Cytotherapy
Verified
Journal Article
Closed access
AMAtsushi Marumo
Atsushi Marumo
YNYasunobu Nagata
Yasunobu Nagata
MFMachiko Fujioka
Machiko Fujioka
SKShuhei Kurosawa
Shuhei Kurosawa
YNYuho Najima
Yuho Najima
HIHidehiro Itonaga
Hidehiro Itonaga

25 December 2023 in Journal of Nippon Medical School
Verified
Journal Article
Open access
PDF file
AMAtsushi Marumo
Atsushi Marumo
HSHisae Sugihara
Hisae Sugihara
IOIkuko Omori
Ikuko Omori
EMEriko Morishita
Eriko Morishita
Acquired hemophilia A (AHA) is a rare disease in which an autoantibody causes bleeding by interacting with and inhibiting the coagulation activity of endogenous factor VIII (FⅧ). Most cases of AHA are idiopathic, and other causes include autoimmune diseases, malignant tumors, pregnancy, drugs, and viral infections. An 86-year-old man was diagnosed with AHA based on the following results: activated partial thromboplastin time (aPTT) extension of 130.7 seconds, inhibitor pattern by mixing study, endogenous factor VIII (FⅧ) level at 5.1 Bethesda units (BU). The activity of von Willebrand factor (vWF) decreased (<10%), which was considered to be a complication of acquired von Willebrand syndrome (AVWS). The patient was started on prednisolone, and the inhibitor level eventually became negative. vWF values also became normal. However, 1 year later, he was hospitalized due to Coronavirus disease 2019 (COVID-19). His blood test showed an aPTT extension of 110.5 seconds, FⅧ level at 4%, and FⅧ inhibitor titer at 0.8 BU; thus, he was diagnosed with a relapse of AHA. After the administration of corticosteroid and remdesivir, he recovered from COVID-19 and AHA. The inhibitor level became negative on the 9th day of admission. Several articles have reported that COVID-19 infection and vaccination are implicated with AHA. We suggest that the aPTT should be measured when patients with AHA are infected with SARS-CoV2 to confirm AHA relapse.

23 March 2024 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
HSHisae Sugihara
Hisae Sugihara
AMAtsushi Marumo
Atsushi Marumo
HOHaruka Okabe
Haruka Okabe
KKKiyotaka Kohama
Kiyotaka Kohama
TMTakashi Mera
Takashi Mera
EMEriko Morishita
Eriko Morishita

5 April 2026 in British Journal of Haematology
Verified
Journal Article
Closed access
HIHidehiro Itonaga
Hidehiro Itonaga
YMYasushi Miyazaki
Yasushi Miyazaki
NTNoriaki Tachi
Noriaki Tachi
SKShuhei Kurosawa
Shuhei Kurosawa
AMAtsushi Marumo
Atsushi Marumo
TTTakayoshi Tachibana
Takayoshi Tachibana